Eastman Chemical (EMN) Liabilities and Shareholders Equity (2009 - 2026)

Eastman Chemical (EMN) has reported Liabilities and Shareholders Equity for 18 consecutive years, with $15.4 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Liabilities and Shareholders Equity rose 1.35% year-over-year to $15.4 billion; the trailing twelve-month figure through Jun 2026 stood at $60.5 billion (changed 0.03% YoY), and the FY2025 full-year result was $14.9 billion, down 2.33% from the prior year.
• Liabilities and Shareholders Equity climbed to $15.4 billion in Q2 2026 per EMN's latest filing, from $15.2 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $15.8 billion in Q1 2022 and bottomed at $14.6 billion in Q3 2023.
• Historically, Liabilities and Shareholders Equity has averaged $15.0 billion across 5 years, with a median of $15.0 billion in 2025.
• The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity dropped 7.84% in 2022, then gained 3.96% in 2024.
• Over 5 years, Liabilities and Shareholders Equity stood at $14.7 billion in 2022, then slipped by 0.23% to $14.6 billion in 2023, then climbed by 3.96% to $15.2 billion in 2024, then decreased by 2.33% to $14.9 billion in 2025, then grew by 3.8% to $15.4 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $15.4 billion, $15.2 billion, and $14.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.